Nucleai, a leader in AI-powered spatial biology analytics, and Sirona Dx, a Technical CRO, specialized in spatial biology and single-cell services, today announced a strategic partnership to deliver a ...

Funding will enable progress on the ADCE-T02 Phase I Tiffany-01 cohort expansion in a range of solid tumours.

Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development. By combining molecular targeting with controlled radiation delivery, these therapies introduce a ...

Patent issued for precision-engineered scar tissue release tools designed for connective tissue fibrosis and fascial ...

Scientists have made a significant breakthrough in understanding Crohn’s disease, identifying what drives the development of ...

As access to gender-affirming care for minors narrows, clinicians are adapting — using nonhormonal options, stronger mental ...

High blood sugar can complicate symptoms of Peyronie’s disease, and getting it under control may help you see improvements.

The field of multifunctional nanomaterials stands at the forefront of Cancer Therapy and Tissue Regeneration. Diseases such ...

A research paper by scientists at University of Oxford presented a humanoid robotic bioreactor capable of delivering ...

Former Castle Biosciences SVP brings proven diagnostic commercialization and reimbursement leadership to NovaScan’s ...

In this Q&A, Jenna DiRito, PhD, COO and co-founder of Revalia Bio, discusses how earlier, human-relevant data is reshaping go ...